Menashe Benjamin, PhD[email protected]PACS/VNAThe Case for Reconstructed PACS: It's the functionality that mattersThe concept of "deconstructed PACS" has generated much interest and controversy, but does it make the most sense for healthcare institutions? In a counterpoint to the deconstructed PACS argument, Menashe Benjamin, PhD, of Carestream Health claims that a single-vendor approach -- reconstructed PACS -- can better serve customers, yielding an enterprise imaging platform without the headaches of a deconstructed PACS model.January 27, 2016Page 1 of 1Top StoriesAIU.S. FDA may need to clarify SaMD validation standardsIn a video interview, a Dana-Farber Cancer Institute expert describes what the "rigor spectrum" is in validation study designs.Molecular ImagingPSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancerWomens ImagingPreop breast MRI improves surgical planning, but use disparities remainWomens ImagingFIGO classification from MRI leads to moderate agreement among radsSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar